458 related articles for article (PubMed ID: 27308732)
1. Endometrial cancer: Not your grandmother's cancer.
McAlpine JN; Temkin SM; Mackay HJ
Cancer; 2016 Sep; 122(18):2787-98. PubMed ID: 27308732
[TBL] [Abstract][Full Text] [Related]
2. A clinically applicable molecular-based classification for endometrial cancers.
Talhouk A; McConechy MK; Leung S; Li-Chang HH; Kwon JS; Melnyk N; Yang W; Senz J; Boyd N; Karnezis AN; Huntsman DG; Gilks CB; McAlpine JN
Br J Cancer; 2015 Jul; 113(2):299-310. PubMed ID: 26172027
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Targets and Opportunities in Endometrial Cancer: Update on Endocrine Therapy and Nonimmunotherapy Targeted Options.
MacKay HJ; Freixinos VR; Fleming GF
Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-11. PubMed ID: 32239967
[TBL] [Abstract][Full Text] [Related]
4. Current Evidence-Based Systemic Therapy for Advanced and Recurrent Endometrial Cancer.
Gordhandas S; Zammarrelli WA; Rios-Doria EV; Green AK; Makker V
J Natl Compr Canc Netw; 2023 Feb; 21(2):217-226. PubMed ID: 36791759
[TBL] [Abstract][Full Text] [Related]
5. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.
McAlpine J; Leon-Castillo A; Bosse T
J Pathol; 2018 Apr; 244(5):538-549. PubMed ID: 29344951
[TBL] [Abstract][Full Text] [Related]
6. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.
Stelloo E; Nout RA; Osse EM; Jürgenliemk-Schulz IJ; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Nijman HW; Putter H; Bosse T; Creutzberg CL; Smit VT
Clin Cancer Res; 2016 Aug; 22(16):4215-24. PubMed ID: 27006490
[TBL] [Abstract][Full Text] [Related]
7. [Histological and molecular classification of endometrial carcinoma and therapeutical implications].
Genestie C; Leary A; Devouassoux M; Auguste A
Bull Cancer; 2017 Dec; 104(12):1001-1012. PubMed ID: 29031505
[TBL] [Abstract][Full Text] [Related]
8. Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients.
Walsh MD; Cummings MC; Buchanan DD; Dambacher WM; Arnold S; McKeone D; Byrnes R; Barker MA; Leggett BA; Gattas M; Jass JR; Spurdle AB; Young J; Obermair A
Clin Cancer Res; 2008 Mar; 14(6):1692-700. PubMed ID: 18310315
[TBL] [Abstract][Full Text] [Related]
9. TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers.
Schultheis AM; Martelotto LG; De Filippo MR; Piscuglio S; Ng CK; Hussein YR; Reis-Filho JS; Soslow RA; Weigelt B
Int J Gynecol Pathol; 2016 Jul; 35(4):289-300. PubMed ID: 26556035
[TBL] [Abstract][Full Text] [Related]
10. [Increasingly better diagnosis and treatment of endometrial cancer].
Salehi S; Stålberg K; Marcickiewicz J; Rosenberg P; Falconer H
Lakartidningen; 2015 Dec; 112():. PubMed ID: 26646959
[TBL] [Abstract][Full Text] [Related]
11. Molecular bases of endometrial cancer: new roles for new actors in the diagnosis and the therapy of the disease.
Llauradó M; Ruiz A; Majem B; Ertekin T; Colás E; Pedrola N; Devis L; Rigau M; Sequeiros T; Montes M; Garcia M; Cabrera S; Gil-Moreno A; Xercavins J; Castellví J; Garcia A; Ramón y Cajal S; Moreno G; Alameda F; Vázquez-Levin M; Palacios J; Prat J; Doll A; Matías-Guiu X; Abal M; Reventós J
Mol Cell Endocrinol; 2012 Jul; 358(2):244-55. PubMed ID: 22037169
[TBL] [Abstract][Full Text] [Related]
12. The results of gynecologic surveillance in families with hereditary nonpolyposis colorectal cancer.
Ketabi Z; Gerdes AM; Mosgaard B; Ladelund S; Bernstein I
Gynecol Oncol; 2014 Jun; 133(3):526-30. PubMed ID: 24631699
[TBL] [Abstract][Full Text] [Related]
13. Gynecologic Cancers in Lynch Syndrome/HNPCC.
Lu KH; Broaddus RR
Fam Cancer; 2005; 4(3):249-54. PubMed ID: 16136386
[TBL] [Abstract][Full Text] [Related]
14. Bokhman Redux: Endometrial cancer "types" in the 21st century.
Suarez AA; Felix AS; Cohn DE
Gynecol Oncol; 2017 Feb; 144(2):243-249. PubMed ID: 27993480
[TBL] [Abstract][Full Text] [Related]
15. Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?
Gargiulo P; Della Pepa C; Berardi S; Califano D; Scala S; Buonaguro L; Ciliberto G; Brauchli P; Pignata S
Cancer Treat Rev; 2016 Jul; 48():61-8. PubMed ID: 27362548
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic implications of DNA mismatch repair status in endometrial carcinomas.
Shikama A; Minaguchi T; Matsumoto K; Akiyama-Abe A; Nakamura Y; Michikami H; Nakao S; Sakurai M; Ochi H; Onuki M; Satoh T; Oki A; Yoshikawa H
Gynecol Oncol; 2016 Feb; 140(2):226-33. PubMed ID: 26644264
[TBL] [Abstract][Full Text] [Related]
17. Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice.
Jamieson A; McAlpine JN
J Natl Compr Canc Netw; 2023 Feb; 21(2):210-216. PubMed ID: 36791751
[TBL] [Abstract][Full Text] [Related]
18. Data Set for the Reporting of Endometrial Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
Matias-Guiu X; Selinger CI; Anderson L; Buza N; Ellenson LH; Fadare O; Ganesan R; Ip PPC; Palacios J; Parra-Herran C; Raspollini MR; Soslow RA; Werner HMJ; Lax SF; McCluggage WG
Int J Gynecol Pathol; 2022 Nov; 41(Suppl 1):S90-S118. PubMed ID: 36305536
[TBL] [Abstract][Full Text] [Related]
19. Reviewing the molecular mechanisms which increase endometrial cancer (EC) risk in women with polycystic ovarian syndrome (PCOS): time for paradigm shift?
Shafiee MN; Chapman C; Barrett D; Abu J; Atiomo W
Gynecol Oncol; 2013 Nov; 131(2):489-92. PubMed ID: 23822891
[TBL] [Abstract][Full Text] [Related]
20. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA
Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
